Forms & publications for healthcare providers

Find documents including forms, provider publications, how-to-guides and e-commerce specifications. 

Provider demographic updates and contracting forms

Prior authorization

Product/network guides

 

Select “Date” or “Name” below to sort.

Date Sort ascending Name
08/28/2018 QP73-18 Taft Hartley Third Party Administrators and Remote Processing Claims Delays
08/21/2018 QP72-18 Pharmacy Benefit Update - New Drug-Related Step Therapy with Quantity Limit Criteria: Dipeptidyl Peptidase - 4 (DPP-4) Inhibitors
08/21/2018 QP66-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Noctiva (desmopressin acetate)
08/21/2018 QP70-18 Pharmacy Benefit Exclusion for Alferon N (interferon alpha-n3) and Lanoxin (digoxin) Injection for Minnesota Health Care Programs Subscribers
08/21/2018 QP69-18 Universal Pharmacy Policy for Minnesota Health Care Programs Subscribers - Morphine Equivalent Dose (MED) Limit Update
08/21/2018 QP65-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Jynarque (tolvapin)
08/21/2018 QP68-18 Site of Care Drug Infusion/Injection Program
08/21/2018 QP67-18 Pharmacy Benefit Exclusion for Alferon N (interferon alpha-n3), Cytovene (ganciclovir), Foscarvir (foscarnet), Prevymis (letermovir), Trogarzo (ibalizu,ab-uiyk), Vistide (cidofovir) and Zovirax (actclovir)
08/21/2018 QP71-18 Pharmacy Benefit Update - New Drug-Related Step Therapy with Quantity Limit Criteria: Sodium-Glucose Co-Transporter 2 (SGLT-2) Inhibitors
08/14/2018 QP64-18 Action Required: Apply for Designation as a Blue Distinction Center for Spine Surgery